Growth hormone-releasing hormone (GHRH) is a hypothalamic peptide that plays a critical role in controlling the synthesis and secretion of growth hormone by the anterior pituitary. GHRH has also been detected in other nonneural extrahypothalamic tissues, including rat placenta, although its role in the hormonal control of pregnancy and/or fetal development has not yet been defined. Here we present the isolation and characterization of cDNA clones corresponding to rat placental GHRH. The placental GHRH mRNA codes for a pre-pro-GHRH identical to that found in the hypothalamus, suggesting that the mature placental GHRH is identical to its hypothalamic counterpart. Nevertheless, the placental and the hypothalamic GHRH mRNAs differ in the region corresponding to the untranslated exon 1 because of the use of an alternative promoter in the placenta located 10 kilobases upstream from the hypothalamic promoter. A combined mechanism involving the use of tissue-specific alternative promoters and the differential splicing of exon 1 generates the mature GHRH transcript in placenta and hypothalamus. Multiple transcription initiation sites have been found in the placental GHRH mRNA, which correlates to the lack of a consensus TATA box in the promoter region.
Synthesis and secretion of anterior pituitary hormones are under the control of specific hypothalamic releasing and inhibiting hormones. Among them, the growth hormone (GH)-releasing hormone (GHRH) specifically interacts with the pituitary somatotrophs activating GH gene transcription (1, 2) and GH secretion (3, 4) . GHRH also exerts a mitogenic effect on the somatotrophs in vitro (5) and is supposed to play an important role in the growth and differentiation of the GH-secreting cells (6) . At present, little is known about the mechanism of GHRH action, although it apparently interacts with specific cell-surface receptors that trigger the synthesis of cAMP by stimulating adenylate cyclase activity (7, 8) . Nevertheless, this final increase in cAMP is not yet clearly connected to the known GHRH-mediated effects.
Human GHRH is a C-terminal-amidated peptide of 44 amino acids initially isolated from pancreatic tumors (9, 10) . Rat GHRH shares a homology of 67% with human GHRH, is 43 amino acids long, but is not amidated (11, 12) . After cloning ofthe corresponding cDNAs, GHRH was established to originate from a precursor (pre-pro-GHRH) that is processed to mature GHRH by removal of the signal peptide and proteolytic cleavage at the N-and C-terminal regions (13) (14) (15) . GHRH is encoded by a single-copy gene that has been cloned and characterized in humans and rat. In both species, the gene is organized into five small exons spanning over 10 kilobases (kb) on genomic DNA and encodes a mRNA of -700 nucleotides (nt) (15, 16) .
In the last few years several reports have indicated the presence of hypothalamic hormones, including GHRH, in nonneural extrahypothalamic tissues. Immunoreactivity against GHRH has been detected in a variety of sites, such as the gastrointestinal tract (17, 18) , pancreas (19) , testis (20) , placenta (21, 22) , and tumors (23, 24) . Because of the importance of the placenta in the hormonal control of pregnancy in mammals, the study of the role of GHRH produced in the placenta is of special interest.
Recent results from our laboratory and others have shown that the GHRH gene is actively transcribed in rat (25, 26) and mouse (27) placenta. To further characterize GHRH expression in the placenta we present here the isolation of cDNA clones corresponding to rat placental GHRH mRNA.t We also report that placental and hypothalamic GHRH mRNAs differ in the region corresponding to the first exon as a consequence of the use in placenta of an alternative promoter located 10 kb upstream from the hypothalamic promoter.
MATERIALS AND METHODS
cDNA Cloning and Sequencing. A Agt1l cDNA library was constructed using poly(A)+ RNA obtained from placentas of Sprague-Dawley rats on gestational days 18-20 following described protocols (28) . Before amplification, the library was screened by using a cDNA corresponding to human GHRH as a probe (14) . The inserts ofthe positive clones were sequenced by the dideoxynucleotide chain-termination method using T7 DNA polymerase (either from Pharmacia or United States Biochemical).
Southern Blot Analysis. Rat genomic DNA was digested with restriction enzymes, fractionated by electrophoresis on 1% agarose gels, transferred to nylon membranes (Nytran; Schleicher & Schuell), and hybridized to 32P-radiolabeled probes according to standard procedures (29, 30) .
RNA Blot Analysis. Total RNA from Sprague-Dawley rat placentas was obtained by successive phenol/chloroform and chloroform extractions of frozen disgregated tissue, followed by ethanol and lithium chloride precipitations (29, 30) . Poly(A)+ RNA fractions were obtained by affinity chromatography through oligo(dT)-cellulose (29) . RNA samples were fractionated by electrophoresis on 1% agarose/formaldehyde gels, transferred to nylon membranes (Nytran; Schleicher & Schuell) , and hybridized to 32P-radiolabeled probes, according to standard procedures (29, 30) . Northern (RNA) blot analysis was also done using as probes the synthetic oligonucleotides 5'-TGCAGTTGTGGGATCCAGGC-3' (Oligo-1) and 5'- TfCTCCGTCCTGGGCCTGCATG1T-3' (Oligo-2) complementary to the placental GHRH mRNA (see Fig. 4D ).
Isolation and Characterization of Genomic Clones. A rat genomic library constructed in ACharon 4A (Clontech) was screened with a DNA fragment corresponding to exon 1P as a probe (see Results). Positive clones were characterized by restriction mapping, Southern blot analysis, and DNA sequencing.
Determination of the Transcription Start Point. The 5' end of rat placental GHRH mRNA was determined by primer extension and RNase protection analyses. Primer-extension analysis was done by hybridizing 32P-end-labeled Oligo-1 to 10 gg of rat placental poly(A)+ RNA and extending the primer with avian myeloblastosis virus reverse transcriptase (Boehringer Mannheim), as described (29, 30) . For RNase protection analysis, a genomic fragment extending 462 base pairs (bp) upstream from the BamHI site at position -40 (see Fig. 4D ) was subcloned into Bluescript to generate an antisense RNA probe that was hybridized to 10 jug of rat placental poly(A)+ RNA and digested with RNase T1 (Bethesda Research Laboratory) and RNase A (Boehringer Mannheim), as described (29, 30 
RESULTS
Previous data from our laboratory revealed the presence in rat placenta of a transcript of :700 nt hybridizing to a human GHRH cDNA clone (26) . To characterize this mRNA we screened =200,000 recombinant clones of an unamplified cDNA library from rat placenta using as a probe the 32P_ labeled EcoRI-BamHI fragment of human GHRH cDNA clone phGRF-54 (14) . Five positive clones were purified after repeated plating. Their inserts were subcloned into EcoRIdigested Bluescript plasmids and sequenced. Fig. 1) , which is identical to rat hypothalamic pre-pro-GHRH (15) . Nevertheless, the alignment of the nucleotide sequence of the placental and the hypothalamic cDNA clones revealed that they were completely different in the region upstream from the splice junction between hypothalamic exons 1 and 2, although they were identical downstream from this position (exons 2-5). Because in both cases the different region is part of the mRNA untranslated leader, this difference is not reflected in the encoded products.
To further characterize the placental GHRH mRNA untranslated leader, several approaches were undertaken. On the one hand, a computer search against a data bank showed no homology to any reported sequence. On the other hand, Southern blot analysis revealed that the GHRH mRNA untranslated leader hybridized to single genomic restriction fragments ( Fig. 2A) , thus indicating that it corresponds to a single-copy sequence in the rat genome. In addition, Northern blot analyses of rat placental RNA were done using as probes: (i) the human GHRH cDNA clone phGRF-54, (ii) a cDNA fragment containing most of the placental GHRH mRNA untranslated leader, and (iiM) a cDNA fragment containing exons 2-5 (see legend to Fig. 2B for details) . In all cases, a single transcript of =700 nt was detected (Fig. 2B) .
To determine the genomic organization of the region encoding the placental untranslated leader, =200,000 genomic clones of a rat genomic library were screened with the EcoRI(linker)-BamHI fragment from the cDNA clone ArpGHRH-1 as a probe. Two overlapping clones, ArGHRH-1 and ArGHRH-2 ( Fig. 3A) spanning 22 kb of genomic DNA, were isolated and characterized by restriction enzyme mapping. Fig. 3B shows a composite restriction map of the newly cloned region overlapping that previously described (15) . Southern blot analysis and sequencing data revealed that the placental untranslated leader is encoded by a single exon, hereafter referred to as exon 1P, located 10 kb upstream from the hypothalamic exon 1 (exon 1H) (Fig. 3B) (Fig. 4 A and B ) that are indicated in the nucleotide sequence of Fig. 4D . The relative intensity of the bands in the primer-extension and in the RNase protection analyses indicates that initiation of transcription at the three proximal sites (Fig. 4D) Biochemistry: Gonzdlez-Crespo and Boronat in placenta is of special interest because of the relevant role of this organ in the hormonal control of pregnancy in mammals.
To study the expression of GHRH in placenta, we have cloned and characterized the cDNA corresponding to rat placental pre-pro-GHRH. In this report we have shown that the rat placental GHRH mRNA contains an open reading frame that encodes a polypeptide identical to the hypothalamic pre-pro-GHRH. This observation strongly supports previous data (21, 22, 25) , suggesting that the mature placental GHRH is identical to that found in the hypothalamus. Further, it also suggests that rat placenta must have a mechanism to process the GHRH precursor equivalent, ifnot identical, to that present in the hypothalamus. Nevertheless, the chromatographic detection in placenta, but not in the hypothalamus, of an additional peak of higher molecular weight showing GHRH immunoreactivity (22, 25) suggests that other GHRH-like polypeptides may occur in rat placenta.
In contrast to the identity of placental and hypothalamic GHRH at the protein level, their corresponding mRNAs clearly differ in the 5'-untranslated leader. An increased number of reports indicates that the 5'-untranslated leader is critical in the translatability ofthe mRNAs, thus representing an additional step in the regulation of gene expression in eukaryotic cells (for review, see ref. 31) . In this respect, the formation of stem-loop structures in the untranslated leaders and the presence of AUG triplets preceding the translational initiator AUG are the best-documented mechanisms involved in the control of mRNA translation (31) . For the GHRH gene, it could be speculated that the existence of two different untranslated leaders, one for each tissue-specific transcript, may confer different properties to the translatability of each mRNA. A detailed analysis of the rat GHRH mRNA untranslated leaders revealed several interesting features that could influence the translatability ofthe placental transcripts. On the one hand, the placental, but not the hypothalamic, GHRH untranslated leader contains two pairs of inverted repeats that can potentially generate the stem-loop structures shown in Fig. 5 . Nevertheless, only the stem-loop structure located downstream from the most efficient transcriptional start points would affect the translation of the most abundant placental GHRH transcripts (Fig. 5) . On the other hand, three AUG triplets preceding the initiator are located in the pla-
cental GHRH mRNA at positions -197, -179, and -129 (Fig. 5) . Two short open reading frames of 26 and 41 amino acids initiate at the AUG located at position -197 and -129, respectively, and precede the pre-pro-GHRH peptide. The AUG at -179 is included in the open reading frame starting at the AUG at -197. Because these AUG triplets are located upstream from the most efficient transcriptional start points (Fig. 5) , they would only influence the translation of the less abundant placental GHRH transcripts. In contrast, the hypothalamic GHRH mRNA contains only one AUG codon (out of frame) in its 5'-untranslated leader, and its proximity to the mRNA 5' end (only 3 nt downstream) makes it very unlikely to be efficiently used (32). Another feature of the placental untranslated leader is the high number of CUG triplets (nine) preceding the AUG initiator codon. As recent reports have revealed that CUG codons can be used as initiator codons in eukaryotic cells (33) (34) (35) and that in all cases they are related with the synthesis of extended protein products (33) (34) (35) , we examined this fact in relation to the presence of the high-molecular-weight forms of GHRH detected in rat placenta (22, 25) . Nevertheless, the presence of an UGA stop codon in frame with the initiator AUG and located at position -6 discards the possibility that the highermolecular-weight forms of placental GHRH arise from the use of any of these upstream CUG codons.
The different untranslated leaders in placental and hypothalamic GHRH transcripts result from alternative splicing of the first exon in combination with the use of an alternative promoter. Data obtained from the recently isolated mouse hypothalamic and placental GHRH cDNA clones (27, 36) suggest that mouse GHRH gene transcription can also be directed by two tissue-specific alternative promoters. Nevertheless, no experimental evidence for it has yet been provided.
The results from mapping the 5' end ofthe placental GHRH mRNA revealed multiple transcriptional start sites scattered over 117 bp (Fig. 4D) . When the nucleotide sequence of the region preceding these sites was examined, neither TATA box nor G+C-rich sequences were found. As described in other TATA-less promoters, lack of a TATA box in the placental GHRH promoter is probably the reason for the multiple transcription start sites (ref. 37 and the references therein). Nevertheless, the placental GHRH 5'-flanking region contains the sequence 5'-CGTCCTGCT-3' (position -153) that is similar to the sequence 5'-CTCCCTGCT-3' located at an equivalent position in the 5'-flanking region of the murine Thy gene, which also lacks TATA and G+C boxes and has multiple transcription start sites (38, 39) . Similar sequences are also found in other genes with multiple transcription start sites but containing G+C boxes (38) . In addition, a putative inverse CCAAT box, similar to that found also in the promoter region of the murine Thy gene (38) and in the human placental estradiol 17p-dehydrogenase gene (40) , is located at position -223 (Fig. 4D) . In spite of the existence of multiple transcriptional start points, the three proximal sites are the most efficient. This situation resembles that found in other placental genes, such as the human estradiol 17,8-dehydrogenase (40) and the human corticotropin-releasing hormone (41) genes that, although they present a major transcription start site at the appropriate distance from a TATA box, also show other less efficient transcription start sites upstream.
The use in placenta of a promoter different from the hypothalamic promoter could be reflected in a different control of GHRH gene transcription in both tissues. At present, no data have yet been reported concerning the regulation of GHRH gene transcription, either in hypothalamus or in tumors. Nevertheless, some studies on transgenic mice expressing a GHRH minigene under control of a metallothionein promoter led to the suggestion that some tissuespecific regulatory elements may be located within the second intron, the 3' end of the mRNA, or the 3'-flanking region (42) . It is worthwhile pointing out that these three regions are depleted of repetitive DNA, which is abundant along the rest of the human GHRH gene (43) . Thus, the differential and tissue-specific control of GHRH gene transcription would also involve elements located either into the gene or in its flanking regions. The transient existence of the placenta raises the question as to whether GHRH gene expression is developmentally regulated or, alternatively, triggered and/or modulated by other hormonal factors. Functional analysis of the GHRH placental promoter, either in vitro or in vivo, will give clues about the regulation of its expression.
